Quality and compliance

Quality is how we protect every shipment

Our quality system is designed to protect product integrity, patient safety and the legitimate medicines supply chain. Documented controls apply to the customers, suppliers, products, premises, records and distribution routes within our responsibility.

Licence statusThe wholesale distribution authorisation (WDA(H)) is being transferred to Vibace Pharma Ltd from its sister company Haoma Pharma Ltd; both companies are owned by Vibace Holding Ltd. Vibace Pharma does not trade in medicines under Haoma Pharma's licence. Licence details will be published here once the transfer is complete.

A GDP-led quality culture

Our procedures and records are built around Good Distribution Practice and cover governance, training, supplier and customer qualification, storage, distribution, deviations, complaints, recalls, returns, change control and continual improvement.

A Responsible Person oversees wholesale-distribution compliance and the effectiveness of the pharmaceutical quality system.

Knowing who we work with

We assess prospective customers, suppliers and service providers before approval and review them periodically using a risk-based approach. Qualification may include verification of corporate identity, regulatory licences, authorised activities, premises, contacts, product scope and proposed transaction routes.

Gloved hands checking medicine vials in a tray during a Good Distribution Practice quality check

Maintaining control through the supply chain

We maintain transaction, batch and distribution records for products handled within our scope. Storage and transport requirements are assessed against product information and approved arrangements, including temperature controls where applicable.

Concerns about suspected falsified, damaged, diverted or otherwise unsuitable products are escalated through the quality system and handled under documented procedures.

Tell us when something needs attention

For a product quality complaint, suspected falsified medicine, recall-related enquiry or distribution concern involving Vibace Pharma, email info@vibacepharma.com with the product name, strength, dosage form, batch number, expiry date, order reference and a short description.

For urgent safety concerns telephone +44 20 8133 2123. Patients seeking medical advice should contact a healthcare professional or emergency service.

Verifying our authorisation

Once the licence transfer is complete, our WDA(H) details will be published on this page and can be independently checked through the MHRA public registers. Until then we share the status directly with prospective customers and partners during onboarding.

Legal entity
Vibace Pharma Ltd, registered in England and Wales
Company number
16875123
Registered office
419 Highland House, 165 The Broadway, Wimbledon, SW19 1NE, United Kingdom
WDA(H)
Being transferred from sister company Haoma Pharma Ltd (both owned by Vibace Holding Ltd). Licence number to follow.
GDP certificate
To follow on completion of the licence transfer.

Questions about our quality system?

We can explain how qualification, documentation and traceability apply to your organisation and products.

Contact our team